Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer.
Saved in:
| Title: | Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Lin SH; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Electronic address: shlin@mdanderson.org., Lin HY; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Verma V; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Xu-Welliver M; Department of Radiation Oncology, Ohio State University, Columbus, OH, USA., Thall PF; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Yao L; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Kim PY; Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Gombos DS; Department of Ophthalmology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Kawedia JD; Clinical Pharmacy Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Komaki R; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Gomez DR; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Nguyen QN; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., O'Reilly MS; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Lu C; Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Fossella FV; Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Skoulidis F; Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Zhang J; Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Tsao AS; Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Heymach JV; Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Blumenschein GR; Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. |
| Source: | Cancer treatment and research communications [Cancer Treat Res Commun] 2022; Vol. 30, pp. 100514. Date of Electronic Publication: 2022 Jan 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
